|
|
(12 intermediate revisions by the same user not shown) |
Line 28: |
Line 28: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hypertrophic cardiomyopathy historical percpective|Historical Perspective]] | | [[Hypertrophic cardiomyopathy historical perspective|Historical Perspective]] |
| |- | | |- |
| ! | | ! |
Line 89: |
Line 89: |
| ! | | ! |
| [[Hypertrophic cardiomyopathy diagnostic study of choice|Diagnostic Study of Choice]] | | [[Hypertrophic cardiomyopathy diagnostic study of choice|Diagnostic Study of Choice]] |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy screening|Genetic Testing & Screening]]
| |
| |- | | |- |
| ! | | ! |
Line 125: |
Line 119: |
| ! | | ! |
| [[Hypertrophic cardiomyopathy x ray|X Ray]] | | [[Hypertrophic cardiomyopathy x ray|X Ray]] |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy chest x ray|Chest X Ray]]
| |
| |- | | |- |
| ! | | ! |
Line 161: |
Line 149: |
| ! | | ! |
| [[Hypertrophic cardiomyopathy other diagnostic studies|Other Diagnostic Studies]] | | [[Hypertrophic cardiomyopathy other diagnostic studies|Other Diagnostic Studies]] |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy CT|CT]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy echocardiography|Echocardiography]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy cardiac catheterization|Cardiac Catheterization]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy positron emission tomography|Positron Emission Tomography]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy electrophysiologic testing|Electrophysiologic Testing]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hypertrophic cardiomyopathy stress testing|Stress Testing]]
| |
| |- | | |- |
| ! | | ! |
Line 208: |
Line 160: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| Medical Therapy
| | [[Hypertrophic cardiomyopathy medical therapy|Medical Therapy]] |
| :[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]
| |
| :[[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]]
| |
| :[[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]]
| |
| :[[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Guidelines]]
| |
| |- | | |- |
| ! | | ! |
Line 249: |
Line 197: |
| ! | | ! |
| [[Hypertrophic cardiomyopathy Future or investigational therapies|Future or Investigational Therapies]] | | [[Hypertrophic cardiomyopathy Future or investigational therapies|Future or Investigational Therapies]] |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| Invasive Therapy
| |
| :[[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]]
| |
| :[[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]]
| |
| :[[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]]
| |
| :[[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]]
| |
| :[[Hypertrophic cardiomyopathy invasive therapy guidelines|Guidelines]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Hypertrophic cardiomyopathy surgery#Cardiac transplantation|Cardiac transplantation]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| Special Scenario
| |
| :[[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Asymptomatic Patients (DO NOT EDIT)|Asymptomatic Patients]]
| |
| :[[Hypertrophic cardiomyopathy management during childhood|Management During Childhood]]
| |
| :[[Hypertrophic cardiomyopathy activities and circumstances to avoid|Activities/Circumstances to Avoid]]
| |
| :[[Hypertrophic cardiomyopathy management during pregnancy|Management During Pregnancy]]
| |
| |- | | |- |
| ! | | ! |